We are live on
!
Find out more
EP
Eversept Partners Portfolio holdings
AUM
$1.52B
1-Year Est. Return
121.13%
This Fund
S&P 500
1 Year Est. Return
+121.13%
AUM
$1.52B
AUM Growth
-$266M
(-15%)
Holding
147
Top Buys
| 1 | +$44.7M | |
| 2 | +$35.8M | |
| 3 | +$33.9M | |
| 4 |
ABVX
Abivax
ABVX
|
+$32.7M |
| 5 |
Omega Healthcare
OHI
|
+$26.7M |
Top Sells
| 1 | +$48.5M | |
| 2 | +$42.6M | |
| 3 | +$38.7M | |
| 4 |
Viridian Therapeutics
VRDN
|
+$31.7M |
| 5 |
Bruker
BRKR
|
+$27.9M |
Sector Composition
| 1 | Healthcare | 92.92% |
| 2 | Real Estate | 6.98% |
| 3 | Financials | 0.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
United Therapeutics
UTHR
$23.5B
| $157M | 10.33% |
264,271
+11,679
|
|
||
|
ABVX
2
Abivax
ABVX
$8.19B
| $104M | 6.86% |
934,423
+276,589
|
|
||
3
GSK
GSK
$103B
| $98.5M | 6.49% |
1,785,175
-894,546
|
|
||
4
Vera Therapeutics
VERA
$2.28B
| $87.4M | 5.76% |
2,173,286
-899,018
|
|
||
5
Natera
NTRA
$31.9B
| $76.9M | 5.07% |
384,713
+50,220
|
|
||
6
Syndax Pharmaceuticals
SNDX
$1.57B
| $67.4M | 4.44% |
2,885,622
-428,786
|
|
||
7
Celldex Therapeutics
CLDX
$2.32B
| $56.7M | 3.74% |
1,788,016
+353,291
|
|
||
8
Vaxcyte
PCVX
$6.77B
| $53.7M | 3.54% |
924,193
-273,529
|
|
||
9
Brookdale Senior Living
BKD
$3.07B
| $48.8M | 3.22% |
3,568,555
+3,193,626
|
|
||
10
Ionis Pharmaceuticals
IONS
$12.3B
| $47.5M | 3.13% |
632,100
+93,882
|
|
||
11
HCA Healthcare
HCA
$83.2B
| $37.5M | 2.47% |
79,229
-16,645
|
|
||
12
Welltower
WELL
$146B
| $35.8M | 2.36% |
+180,953
|
|
||
13
Healthpeak Properties
DOC
$14.1B
| $32.5M | 2.15% |
+1,981,070
|
|
||
14
Insulet
PODD
$11.1B
| $30.1M | 1.99% |
143,546
+68,838
|
|
||
15
BioCryst Pharmaceuticals
BCRX
$2.12B
| $28.9M | 1.91% |
3,039,820
+46,925
|
|
||
16
Geron
GERN
$719M
| $28.1M | 1.85% |
18,834,883
+1,174,900
|
|
||
|
17
Omega Healthcare
OHI
$13.6B
| $25.7M | 1.69% |
+585,680
|
|
||
18
Liquidia Corp
LQDA
$5.69B
| $25.6M | 1.68% |
677,392
+167,949
|
|
||
19
Community Health Systems
CYH
$404M
| $25.5M | 1.68% |
8,677,281
+733,479
|
|
||
20
Avantor
AVTR
$6.77B
| $23.3M | 1.54% |
2,974,287
-202,357
|
|
||
21
Qiagen
QGEN
$7.79B
| $21.8M | 1.44% |
+545,330
|
|
||
22
Encompass Health
EHC
$10.3B
| $18.8M | 1.24% |
194,104
+87,178
|
|
||
23
Eli Lilly
LLY
$1.02T
| $17.5M | 1.15% |
19,000
+8,377
|
|
||
24
Travere Therapeutics
TVTX
$4.52B
| $16.1M | 1.06% |
542,610
-632,358
|
|
||
25
CytomX Therapeutics
CTMX
$649M
| $15M | 0.99% |
3,188,514
+681,424
|
|